240 related articles for article (PubMed ID: 37546800)
1. Cocaine Regulates Antiretroviral Therapy CNS Access Through Pregnane-X Receptor-Mediated Drug Transporter and Metabolizing Enzyme Modulation at the Blood Brain Barrier.
Fridman LB; Knerler S; Price AS; Ortiz RC; Mercado A; Wilkins H; Flores BR; Orsburn BC; Williams DW
bioRxiv; 2023 Jul; ():. PubMed ID: 37546800
[TBL] [Abstract][Full Text] [Related]
2. Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier.
Colón Ortiz R; Knerler S; Fridman LB; Mercado A; Price AS; Rosado-Franco JJ; Wilkins H; Flores BR; Orsburn BC; Williams DW
Fluids Barriers CNS; 2024 Jan; 21(1):5. PubMed ID: 38200564
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
4. Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood-brain barrier model.
Ghosh C; Hossain M; Mishra S; Khan S; Gonzalez-Martinez J; Marchi N; Janigro D; Bingaman W; Najm I
Epilepsia; 2018 Nov; 59(11):2049-2060. PubMed ID: 30264400
[TBL] [Abstract][Full Text] [Related]
5. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.
Huang Y; Hoque MT; Jenabian MA; Vyboh K; Whyte SK; Sheehan NL; Brassard P; Bélanger M; Chomont N; Fletcher CV; Routy JP; Bendayan R
J Antimicrob Chemother; 2016 Jul; 71(7):1954-65. PubMed ID: 27076103
[TBL] [Abstract][Full Text] [Related]
7. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells.
Liu CL; Lim YP; Hu ML
Mar Drugs; 2012 Jan; 10(1):242-257. PubMed ID: 22363234
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
Harati R; Villégier AS; Banks WA; Mabondzo A
J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
[TBL] [Abstract][Full Text] [Related]
9. Physical and Metabolic Integrity of the Blood-Brain Barrier in HIV Infection: A Special Focus on Intercellular Junctions, Influx and Efflux Transporters and Metabolizing Enzymes.
Shawahna R
Curr Drug Metab; 2015; 16(2):105-23. PubMed ID: 26179607
[TBL] [Abstract][Full Text] [Related]
10. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors.
Xu D; Huang S; Wang H; Xie W
Drug Metab Rev; 2018 Nov; 50(4):407-414. PubMed ID: 30501435
[TBL] [Abstract][Full Text] [Related]
11. Multiple Faceted Roles of Cocaine in Potentiation of HAND.
Cai Y; Yang L; Callen S; Buch S
Curr HIV Res; 2016; 14(5):412-416. PubMed ID: 27009095
[TBL] [Abstract][Full Text] [Related]
12. In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study.
Chan GN; Saldivia V; Yang Y; Pang H; de Lannoy I; Bendayan R
J Neurochem; 2013 Nov; 127(3):342-52. PubMed ID: 23777437
[TBL] [Abstract][Full Text] [Related]
13. Piperine activates human pregnane X receptor to induce the expression of cytochrome P450 3A4 and multidrug resistance protein 1.
Wang YM; Lin W; Chai SC; Wu J; Ong SS; Schuetz EG; Chen T
Toxicol Appl Pharmacol; 2013 Oct; 272(1):96-107. PubMed ID: 23707768
[TBL] [Abstract][Full Text] [Related]
14. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
Lemmen J; Tozakidis IE; Bele P; Galla HJ
Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
[TBL] [Abstract][Full Text] [Related]
15. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
16. Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.
Slosky LM; Thompson BJ; Sanchez-Covarrubias L; Zhang Y; Laracuente ML; Vanderah TW; Ronaldson PT; Davis TP
Mol Pharmacol; 2013 Nov; 84(5):774-86. PubMed ID: 24019224
[TBL] [Abstract][Full Text] [Related]
17. Physiologically Relevant Concentrations of Dolutegravir, Emtricitabine, and Efavirenz Induce Distinct Metabolic Alterations in HeLa Epithelial and BV2 Microglial Cells.
George JW; Mattingly JE; Roland NJ; Small CM; Lamberty BG; Fox HS; Stauch KL
Front Immunol; 2021; 12():639378. PubMed ID: 34093527
[TBL] [Abstract][Full Text] [Related]
18. Role of constitutive androstane receptor in Toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters.
Shah P; Guo T; Moore DD; Ghose R
Drug Metab Dispos; 2014 Jan; 42(1):172-81. PubMed ID: 24194512
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells.
Tan H; Xu C; Zeng H; Wang Y; Li Y; Fan X; Chen P; Jiang Y; Chen X; Huang M; Bi H
J Pharmacol Sci; 2016 Feb; 130(2):66-71. PubMed ID: 26782648
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]